Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abeona Therapeutics (ABEO) Change in Inventory (2025)

Abeona Therapeutics has reported Change in Inventory over the past 4 years, most recently at $643000.0 for Q4 2025.

  • Quarterly results put Change in Inventory at $643000.0 for Q4 2025, changed N/A from a year ago — trailing twelve months through Dec 2025 was $2.8 million (changed N/A YoY), and the annual figure for FY2025 was $5.5 million, changed.
  • Change in Inventory for Q4 2025 was $643000.0 at Abeona Therapeutics, down from $2.2 million in the prior quarter.
  • Over the last five years, Change in Inventory for ABEO hit a ceiling of $2.2 million in Q3 2025 and a floor of $643000.0 in Q4 2025.